MAGLIO, ANGELANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 217
AS - Asia 136
EU - Europa 101
SA - Sud America 23
AF - Africa 3
Totale 480
Nazione #
US - Stati Uniti d'America 210
SG - Singapore 93
IT - Italia 47
CN - Cina 25
BR - Brasile 21
DE - Germania 17
FI - Finlandia 9
GB - Regno Unito 6
CA - Canada 5
IE - Irlanda 5
SE - Svezia 5
HK - Hong Kong 4
FR - Francia 3
IN - India 3
PK - Pakistan 3
AR - Argentina 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
MX - Messico 2
NL - Olanda 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
BD - Bangladesh 1
CY - Cipro 1
GR - Grecia 1
JO - Giordania 1
KE - Kenya 1
TN - Tunisia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 480
Città #
Singapore 75
Dallas 41
Santa Clara 28
Hefei 24
Munich 14
Chandler 10
Ashburn 9
Milan 8
Chicago 6
Lawrence 6
Princeton 6
Dublin 5
Messina 5
Naples 5
Turku 5
Wilmington 5
Helsinki 4
Palermo 4
Boardman 3
Hong Kong 3
Houston 3
London 3
New York 3
Rio de Janeiro 3
Rome 3
San Francisco 3
San Nicola Manfredi 3
Ankara 2
Boston 2
Brooklyn 2
Fisciano 2
Hanover 2
Lamezia Terme 2
Los Angeles 2
Miami 2
Olomouc 2
Warsaw 2
Al Kazimiyah 1
Amman 1
Athens 1
Atlanta 1
Barreiras 1
Barueri 1
Belo Horizonte 1
Brasília 1
Buffalo 1
Cajamar 1
Cariacica 1
Cataguases 1
Caucaia 1
Charlotte 1
Cincinnati 1
Des Moines 1
Elba 1
Elk Grove 1
Erie 1
Fayetteville 1
Garland 1
Hackensack 1
Huntersville 1
Indianapolis 1
Islamabad 1
Itaperuna 1
Jaraguá do Sul 1
Jersey City 1
Jodhpur 1
Johannesburg 1
Karachi 1
Kyiv 1
Luhansk 1
Manchester 1
Marcianise 1
Mascalucia 1
Massapequa 1
Mesquite 1
Mexico City 1
Milwaukee 1
Montreal 1
Mumbai 1
Nabeul 1
Nairobi 1
Najaf 1
Oxon Hill 1
Pasadena 1
Passa e Fica 1
Pontotoc 1
Poplar 1
Porto Alegre 1
Puerto Rico 1
Raleigh 1
Recife 1
San Juan Bautista 1
Santa Maria 1
Senador Canedo 1
Sezze 1
Sorocaba 1
Stockholm 1
Surubim 1
São José do Rio Preto 1
Topeka 1
Totale 370
Nome #
Tezepelumab: A potential new biological therapy for severe refractory asthma 33
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 33
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 32
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 31
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 29
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 27
Novel Biological Therapies for Severe Asthma Endotypes 23
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 23
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 22
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 22
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 22
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 21
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 20
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 20
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 19
Phenotyping severe asthma: a rationale for biologic therapy 19
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 17
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 17
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 17
Novel Biological Therapies for Severe Asthma Endotypes 17
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 13
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 12
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 11
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 11
Totale 511
Categoria #
all - tutte 6.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 2 0 0 0 0 0 0 0 0
2021/202223 0 0 2 4 2 1 1 5 3 3 2 0
2022/202344 14 3 8 0 2 1 1 2 3 1 8 1
2023/202447 13 4 6 2 2 6 1 2 1 4 4 2
2024/2025245 22 4 0 4 32 43 13 7 13 4 41 62
2025/2026149 46 87 16 0 0 0 0 0 0 0 0 0
Totale 511